Amplifications of EGFR and ERBB2 were found only in immune deficient MPNSTs (n = 3 tumours with ≥15 additional copies of EGFR and n = 1 tumour with 9 additional copies of ERBB2). Here, ERBB2 is linked to neoplasm.